FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2506077334> ?p ?o ?g. }

• W2506077334 endingPage "e103" @default.
• W2506077334 startingPage "e102" @default.
• W2506077334 abstract "The meta-analysis by Cao and colleagues1 pools data from retrospective cohort studies to assess the importance of location of withdrawal of life-sustaining therapies (WLST) (intensive care unit [ICU] vs operating theater [OT]) and premortem heparin administration in liver transplantation after donation after cardiocirculatory determination of death (DCD). The authors assert that “withdrawal in the OT and premortem heparin administration improve DCD liver transplant outcomes.” These conclusions are overstated and not sufficiently reflective considering the low quality of data: None of the studies actually compared outcomes based on location of WLST or premortem heparin administration. Rather, they were single-center comparisons of transplantation outcomes in DCD versus donation after brain death (DBD). Studies were performed over a span of longer than 30 years, in multiple countries, at centers with varying degrees of experience with DCD, and with substantial heterogeneity in cold and warm ischemic time (WIT). An association from observational studies does not prove causation, particularly in an unadjusted univariate analysis. Such data are, at best, hypothesis-generating. Outcomes were consistently superior with transplantation after DBD, irrespective of the location of WLST and use of heparin. Even if the odds of poor outcomes with DCD versus DBD were numerically greater when WLST occurred in ICU, or when heparin was withheld, no comparative analyses were presented in the article. For the data in Figures 31 and 51 (allograft and patient survival, respectively), we have generated mixed effects models to compare studies where WLST occurred in the ICU versus OT. In neither case were the results statistically significant (P = 0.58 and 0.13, respectively). Similarly, for data presented in Figure 71 (primary graft nonfunction), there was no significant difference based on whether or not premortem heparin was administered (P = 0.21). We have expanded the authors' analysis to assess allograft failure based on whether or not heparin was administered (data not presented in the manuscript). The odds ratio for graft failure in DCD versus DBD was 1.7 (1.3-2.3) with heparin and 1.6 (0.6-4.6) without (Figure 1; P = 0.92).FIGURE 1: Comparison of 1-year rates of allograft failure in liver transplantation following donation after cardiocirculatory death vs. donation after brain death, categorized by use of premortem heparin.Minimizing WIT is important, but existing literature does not demonstrate that WLST should occur in the OT. Although WIT may be slightly longer, the ICU environment is usually much better suited to provide end-of-life care to organ donors and their families. Despite the rationale for premortem anticoagulation, there is little human data to support the need for it. Outcomes have proven favorable in jurisdictions where premortem heparin is not used.2,3 The impact of anticoagulation in DCD may vary depending on the organ system.3–5 There is essentially no research assessing optimal dosing of heparin in DCD, which is typically much higher than what is required for therapeutic anticoagulation (>300 units/kg vs ≈ 80 units/kg). There is justifiable concern that such high-dose heparin could worsen intracranial hemorrhage in brain-injured patients. Heparin is commonly administered before WLST, even though a sizable proportion of potential donors do not die within the requisite time frame. To avoid this scenario, some centers wait to administer heparin until it is clear that the patient will actually become an organ donor. The work of Cao and colleagues highlights the need to better study these issues, rather than justifying a call for practice changes that are unsupported by existing data and may compromise optimal end-of-life care in DCD donors." @default.
• W2506077334 created "2016-08-23" @default.
• W2506077334 creator A5022847508 @default.
• W2506077334 creator A5052459990 @default.
• W2506077334 date "2016-10-01" @default.
• W2506077334 modified "2023-10-07" @default.
• W2506077334 title "Premortem Heparin Administration and Location of Withdrawal of Life-Sustaining Interventions in DCD" @default.
• W2506077334 cites W1870104539 @default.
• W2506077334 cites W2048867442 @default.
• W2506077334 cites W2153902346 @default.
• W2506077334 cites W2313834608 @default.
• W2506077334 doi "https://doi.org/10.1097/tp.0000000000001378" @default.
• W2506077334 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27482963" @default.
• W2506077334 hasPublicationYear "2016" @default.
• W2506077334 type Work @default.
• W2506077334 sameAs 2506077334 @default.
• W2506077334 citedByCount "10" @default.
• W2506077334 countsByYear W25060773342019 @default.
• W2506077334 countsByYear W25060773342020 @default.
• W2506077334 countsByYear W25060773342021 @default.
• W2506077334 countsByYear W25060773342022 @default.
• W2506077334 crossrefType "journal-article" @default.
• W2506077334 hasAuthorship W2506077334A5022847508 @default.
• W2506077334 hasAuthorship W2506077334A5052459990 @default.
• W2506077334 hasConcept C126322002 @default.
• W2506077334 hasConcept C159110408 @default.
• W2506077334 hasConcept C167135981 @default.
• W2506077334 hasConcept C177713679 @default.
• W2506077334 hasConcept C194828623 @default.
• W2506077334 hasConcept C201903717 @default.
• W2506077334 hasConcept C23131810 @default.
• W2506077334 hasConcept C27415008 @default.
• W2506077334 hasConcept C2776376669 @default.
• W2506077334 hasConcept C2777557582 @default.
• W2506077334 hasConcept C2911091166 @default.
• W2506077334 hasConcept C71924100 @default.
• W2506077334 hasConceptScore W2506077334C126322002 @default.
• W2506077334 hasConceptScore W2506077334C159110408 @default.
• W2506077334 hasConceptScore W2506077334C167135981 @default.
• W2506077334 hasConceptScore W2506077334C177713679 @default.
• W2506077334 hasConceptScore W2506077334C194828623 @default.
• W2506077334 hasConceptScore W2506077334C201903717 @default.
• W2506077334 hasConceptScore W2506077334C23131810 @default.
• W2506077334 hasConceptScore W2506077334C27415008 @default.
• W2506077334 hasConceptScore W2506077334C2776376669 @default.
• W2506077334 hasConceptScore W2506077334C2777557582 @default.
• W2506077334 hasConceptScore W2506077334C2911091166 @default.
• W2506077334 hasConceptScore W2506077334C71924100 @default.
• W2506077334 hasIssue "10" @default.
• W2506077334 hasLocation W25060773341 @default.
• W2506077334 hasLocation W25060773342 @default.
• W2506077334 hasOpenAccess W2506077334 @default.
• W2506077334 hasPrimaryLocation W25060773341 @default.
• W2506077334 hasRelatedWork W1984720268 @default.
• W2506077334 hasRelatedWork W2042160336 @default.
• W2506077334 hasRelatedWork W2103779230 @default.
• W2506077334 hasRelatedWork W2109147503 @default.
• W2506077334 hasRelatedWork W2128797028 @default.
• W2506077334 hasRelatedWork W2322581019 @default.
• W2506077334 hasRelatedWork W3189248554 @default.
• W2506077334 hasRelatedWork W334096847 @default.
• W2506077334 hasRelatedWork W4235252973 @default.
• W2506077334 hasRelatedWork W4381328000 @default.
• W2506077334 hasVolume "100" @default.
• W2506077334 isParatext "false" @default.
• W2506077334 isRetracted "false" @default.
• W2506077334 magId "2506077334" @default.
• W2506077334 workType "article" @default.